Session Information
-
WCLC 2021
2022 World Conference on Lung Cancer
Presentation Date(s):- September 8 - 14, 2021
- Total Presentations: 1107
All times listed are in Mountain Time MDT (UTC-6:00)
PL - Plenary
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
FP - Featured Posters
P - Posters
WS - Workshops
IS - Industry Symposium
MTE - Meet the Expert
BEDG - Brain Exchange Discussion Groups
September 8 Wed
Sep 8 Thursday
September 9 Thu
Sep 9 Friday
September 10 Fri
Sep 10 Saturday
September 11 Sat
Sep 11 Sunday
September 12 Sun
Sep 12 Monday
September 13 Mon
Sep 13 Tuesday
September 14 Tue
Sep 14
-
+
MA01 - Multimodality Management of Advanced Lung Cancer
- 08:15 - 09:15
- 9/08/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Mini Oral
- Track: Multimodality of Advanced Lung Cancer
-
+
MA01.06 - Effects of the Immunotherapy Era on Maintenance Outcomes in Advanced Nonsquamous NSCLC: Subgroup Analysis of ECOG 5508
08:50 - 08:55 | Presenter: Bharathi Muthusamy
- Abstract
Loading...
-
+
OA01 - The Impact of COVID-19 on Patients with Lung Cancer
- 08:15 - 09:15
- 9/08/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Oral
- Track: Management of Lung Cancer in the Era of COVID-19
- Moderators:Enriqueta Felip
-
+
OA01.04 - Discussant
08:45 - 08:55 | Presenter: Suresh Ramalingam
- Abstract
No abstract available for this presentation
-
+
OA03 - Novel Approaches to Cessation in Cancer Care
- 09:30 - 10:30
- 9/08/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Oral
- Track: Risk Reduction and Tobacco Control
- Moderators:Matthew Allen Steliga
-
+
OA03.03 - Patient Factors Associated With Engagement of an Academic Institution Tobacco Cessation Referral Program
09:50 - 10:00 | Presenter: Sarah Westergaard
- Abstract
Loading...
-
+
IS01 - Industry Symposium Sponsored by Mirati Therapeutics: Rapid Progress During a Pandemic: Emerging Therapeutic Options for NSCLC
- 12:00 - 13:00
- 9/08/2021
- Location: Industry Symposium Auditorium via Industry Hub
- Not for CME Credit
- Type: Industry Supported Symposium
- Track: N.A.
-
+
IS01.02 - Recent Advances and Current Approaches to Address Unmet Needs in Advanced NSCLC
12:05 - 12:20 | Presenter: Suresh Ramalingam
- Abstract
No abstract available for this presentation
-
+
FP01 - Early Stage/Localized Disease/Ablative Therapies
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters (Featured)
- Track: Early Stage/Localized Disease/Ablative Therapies
-
+
FP01.01 - The Association of Bevacizumab with a Decreased Risk of Brain Metastases in ECOG-ACRIN E1505 in Completely Resected Stage IB-IIIA NSCLC
00:00 - 00:00 | Presenter: John Varlotto
- Abstract
Loading...
-
+
FP07 - Mesothelioma, Thymoma and Other Thoracic Malignancies
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters (Featured)
- Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
-
+
FP07.05 - DREAM3R: Durvalumab With Chemotherapy as First Line Treatment in Advanced Pleural Mesothelioma - A Phase 3 Randomised Trial
00:00 - 00:00 | Presenter: Anna Nowak
- Abstract
Loading...
-
+
FP08 - Multimodality Management of Advanced Lung Cancer
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters (Featured)
- Track: Multimodality of Advanced Lung Cancer
-
+
FP08.01 - Lung Stereotactic Body Radiation Therapy for Treatment of Oligoprogressive and Oligorecurrent Metastatic Disease: A Multi-Center Analysis
00:00 - 00:00 | Presenter: Sibo Tian
- Abstract
Loading...
-
+
FP09 - Novel Therapeutics and Targeted Therapies
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters (Featured)
- Track: Novel Therapeutics and Targeted Therapies
-
+
FP09.01 - Mobocertinib in Platinum-Pretreated EGFR Exon 20 Insertion+ Metastatic NSCLC Patients With/Without Prior Anti-PD(L)-1 Therapy
00:00 - 00:00 | Presenter: Pasi A. Janne
- Abstract
Loading... -
+
FP09.02 - Mobocertinib (TAK-788) in EGFR Exon 20 Insertion+ Metastatic NSCLC: Patient-Reported Outcomes From EXCLAIM Extension Cohort
00:00 - 00:00 | Presenter: Maria Rosario García Campelo
- Abstract
Loading...
-
+
FP16 - Tumor Biology and Systems Biology: Basic and Translational Science
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters (Featured)
- Track: Tumor Biology and Systems Biology: Basic and Translational Science
-
+
FP16.03 - Early Circulating-Tumor DNA EGFR Mutation Clearance in Plasma as a Predictor of Clinical Outcomes in The AURA3 Trial
00:00 - 00:00 | Presenter: Myung-Ju Ahn
- Abstract
Loading...
-
+
P50 - Novel Therapeutics and Targeted Therapies - EGFR Minor
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Novel Therapeutics and Targeted Therapies
-
+
P50.05 - Natural History and Real-World Treatment Outcomes for NSCLC Patients with EGFR Exon 20 Insertion Mutation: An IASLC- ASCO CancerLinQ Study
00:00 - 00:00 | Presenter: Madhusmita Behera
- Abstract
Loading...
